This review focuses on thieno[3,2-b]pyrrole‑annulated BODIPYs as an emerging class of heavy‑atom‑free photosensitizers intended for photodynamic therapy (PDT). The annulation approach modifies the canonical BODIPY core to achieve efficient triplet state population while retaining fluorescence and strong near‑infrared (NIR) absorption—properties desirable for biomedical imaging and PDT. The authors aim to synthesize and systematize existing data on the physicochemical basis of these compounds, their synthetic modification, and translational considerations relevant to oncology applications.
The review emphasizes mechanistic understanding, particularly the role of photoinduced charge transfer‑assisted intersystem crossing (PCT‑ISC) in enabling intersystem crossing (ISC) without heavy atoms. It also addresses a deliberate shift from classical oxygen‑dependent photochemistry (Type II) toward radical‑mediated (Type I) pathways to mitigate limitations posed by tumor hypoxia. Practical translational issues—dye aggregation, delivery vehicle effects on in vivo efficacy, and the need for standardized light dosimetry—are discussed to guide rational design of NIR photosensitizers with predictable properties.
A central theme of the review is the PCT‑ISC mechanism as the underlying photophysical process that enables efficient triplet formation in these fused BODIPY systems. By introducing an electron‑donating/withdrawing interplay through the thieno[3,2‑b]pyrrole annulation, excited‑state charge transfer character is promoted. This charge transfer facilitates ISC to the triplet manifold in the absence of heavy atoms that traditionally promote spin–orbit coupling.
The review frames PCT‑ISC as a means to reconcile two often competing requirements for photosensitizers: high triplet yield for reactive species generation and retained NIR absorption/fluorescence for imaging and activation. The abstract does not provide numerical photophysical parameters (e.g., triplet quantum yields, singlet oxygen quantum yields, lifetimes), so readers must consult the full text for quantitative data.
Synthesis and structural modification are described as important levers to tune spectral and photophysical behavior. Annulation of a thieno[3,2‑b]pyrrole moiety onto the BODIPY scaffold is presented as the key structural transformation. The review surveys approaches used to introduce the annulation and further substitutions that modulate charge transfer character, absorption maxima into the NIR, and the balance between fluorescence and triplet formation.
While the abstract indicates that synthetic routes and modifications are examined, it does not detail specific reaction conditions, yields, or stepwise protocols. Those experimental specifics are likely contained in the full text and supporting information of the reviewed articles.
The review highlights a strategic movement away from the classical Type II PDT mechanism, which relies on energy transfer to oxygen to produce singlet oxygen, toward Type I radical‑based chemistry. This shift is motivated by the clinical problem of tumor hypoxia, where oxygen levels are insufficient for efficient Type II photochemistry.
By favoring radical generation or electron transfer pathways, thieno[3,2‑b]pyrrole‑fused BODIPYs can potentially maintain phototoxic activity under low‑oxygen conditions. The abstract presents this conceptual shift but does not provide comparative efficacy data or detailed mechanistic experiments demonstrating rates or yields of radical formation; such data would be found in the primary reports discussed in the review.
Translational application of NIR photosensitizers requires addressing several practical challenges, which the review explicitly considers:
Dye aggregation: Aggregation can alter optical properties, quench fluorescence, and affect triplet formation. The review outlines aggregation as a critical material property that must be controlled in formulation and delivery.
Delivery systems: The impact of carriers (e.g., nanoparticles, liposomes, polymeric matrices) on biodistribution, photophysics in biological media, and in vivo efficacy is discussed as a determinant of clinical relevance. The abstract notes the influence of delivery methods but does not enumerate specific platforms or comparative data.
Light dosimetry standardization: Effective and reproducible PDT requires standardized parameters for light delivery (wavelength, fluence, dose rate). The review raises the need for standardized dosimetry to allow predictable translation from in vitro and preclinical studies to clinical practice.
These issues are presented as obstacles and considerations for future design and testing rather than as resolved problems.
The review compiles current evidence to facilitate rational, mechanism‑informed design of NIR photosensitizers based on the thieno[3,2‑b]pyrrole‑annulated BODIPY motif. Key implications include leveraging PCT‑ISC to achieve triplet generation without heavy atoms, tuning structure to extend absorption into the NIR, and intentionally designing for Type I reactivity to address tumor hypoxia.
The abstract notes that the material systematizes data to aid predictable design, but it does not provide exhaustive experimental parameters or in vivo efficacy outcomes. Readers interested in quantitative photophysical metrics, precise synthetic protocols, or comparative preclinical data should consult the full review and the primary studies it summarizes.
This work is a review article published in Bioorganic Chemistry (Bioorg Chem) in 2026 (PMID: 42048685; DOI: 10.1016/j.bioorg.2026.109928). The authors declare no competing financial interests or personal relationships that could have influenced the reported analysis. The abstract and metadata presented here summarize the review’s scope and conclusions; specific experimental details are not reported in the abstract and require access to the full text for comprehensive technical information.